Pharmacokinetics of echocontrast agent infusion in a dog model

Journal of Neuroimaging

Volumn 11, Issue 3, 2001, Pages 298-302

  Kaps, M ^a,d   Seidel, G ^b   Algermissen, C ^b   Gerriets, T ^a   Broillet, A ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Bracco Suisse SA   (Switzerland)

^d JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Cerebral vessels; Contrast agent; Transcranial Doppler; Ultrasonics

Indexed keywords

CONTRAST MEDIUM; SONOVUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CIRCULATION; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOG; DOPPLER FLOWMETRY; DOSE RESPONSE; IMAGE INTENSIFIER; INFUSION; MALE; NONHUMAN; RADIODIAGNOSIS; SIGNAL DETECTION;

EID: 0034934657     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2001.tb00050.x     Document Type: Article

References (11)

1. Myocardial contrast echocardiography: Relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronar thrombosis and reperfusion
2. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow
3. The influence of different gases of acoustic properties of a spherosome based ultrasound contrast agent (BY963): A transcranial dopplersonography study
4. The Doppler kinetics of microbubble echo contrast
5. BR1: A new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles
6. Pharmakokinetik
7. Contrast enhanced transcranial colour coded sonography (TCCS) in intracranial occlusive lesions
8. Different system setting for transcranial Doppler intensitometry using a new ultrasound contrast agent BR1
9. Acoustic densitometric studies of echocontrast distribution in the brain of dogs
10. Pharmacokinetic studies of different echocontrast agents in the cerebral circulation of dogs
11. Safety and ultrasound-enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation